![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
First ever successful use of Daclatasvir and GS-7977 (Sofosbuvir) , an IFN-free regimen, in a Liver Transplant recipient with severe recurrent Hepatitis C
|
|
|
Reported by Jules Levin
AASLD Nov 2012 Boston
Fontana RJ 1, Hughes EA 2, Bifano M 2, Hindes R 3, Symonds WT 4, Dessislava D 2
1 University of Michigan Medical School, Ann Arbor, MI; 2 Bristol-Myers Squibb, Wallingford, CT; 3 Princeton, NJ, 4 Gilead Sciences, Foster City, CA
![AASLD1.gif](../images/011213/011213-1/AASLD1.gif)
![AASLD2.gif](../images/011213/011213-1/AASLD2.gif)
![AASLD3.gif](../images/011213/011213-1/AASLD3.gif)
![AASLD4.gif](../images/011213/011213-1/AASLD4.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|